Location History:
- Yokohama, JP (1982 - 1984)
- Tokyo, JP (1986 - 2019)
Company Filing History:
8 out of 614 
1 out of 9 
1 out of 61 
Years Active: 1982-2019
Title: Kenichiro Nakao: Innovator in Gynecological Therapeutics
Introduction
Kenichiro Nakao is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of gynecological therapeutics, holding a total of nine patents. His work focuses on developing innovative solutions for estrogen-dependent diseases.
Latest Patents
Nakao's latest patents include an estrogen receptor β partial agonist that has an estrogen receptor α inhibitory effect. This invention aims to provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterine adenomyosis. The solution involves using an estrogen receptor α-inhibiting β partial agonist, represented by a specific formula, as an active ingredient. Additionally, he has developed phenylpiperazine derivatives and their acid addition salts, which are crucial in his therapeutic approaches.
Career Highlights
Throughout his career, Kenichiro Nakao has worked with notable companies, including Mitsubishi Chemical Industries Limited and Nobelpharma Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in medical treatments.
Collaborations
Nakao has collaborated with esteemed colleagues such as Harukazu Fukami and Issei Nitta. These partnerships have fostered a collaborative environment that enhances the development of innovative therapeutic solutions.
Conclusion
Kenichiro Nakao's work in gynecological therapeutics exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to addressing critical health issues faced by women.